Clinical Trial Update: Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous sulbactam-ETX2514 for hospitalized adults with complicated urinary tract infection and acute pyelonephritis has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• sulbactam-ETX2514

Snippet

Sponsor: Entasis Therapeutics | Conditions: Complicated Urinary Tract Infection, Acute Pyelonephritis | Phase 2 | Status: COMPLETED | Results posted: 2019-06-05